{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:12:16Z","timestamp":1757779936870},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Belgian Fonds National de la Recherche Scientifique"},{"name":"Interuniversity Attraction Poles Program-Belgian Science Policy"},{"name":"DIANE Centre of Excellence Programme of the R\u00e9gion Wallonne"},{"name":"Maisin, Goor, and Salus Sanguinis"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.bcp.2010.12.009","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T09:15:20Z","timestamp":1292663720000},"page":"586-593","source":"Crossref","is-referenced-by-count":12,"title":["Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines"],"prefix":"10.1016","volume":"81","author":[{"given":"L.","family":"Bastin-Coyette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cardoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Smal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"de Viron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Arts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Amsailale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Van Den Neste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bontemps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.12.009_bib0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00002512-200522120-00002","article-title":"Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies","volume":"22","author":"Robak","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bcp.2010.12.009_bib0010","first-page":"1113","article-title":"Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review)","volume":"27","author":"Van den Neste","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2010.12.009_bib0015","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/molecules14031183","article-title":"Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases","volume":"14","author":"Robak","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2010.12.009_bib0020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2141.2003.04336.x","article-title":"Mechanism of action of purine analogues in chronic lymphocytic leukaemia","volume":"121","author":"Pettitt","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2010.12.009_bib0025","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1038\/onc.2008.316","article-title":"Nucleoside analogs: molecular mechanisms signaling cell death","volume":"27","author":"Ewald","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.12.009_bib0030","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1182\/blood.V96.10.3537","article-title":"Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria","volume":"96","author":"Genini","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.12.009_bib0035","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1073\/pnas.95.16.9567","article-title":"Induction of an apoptotic program in cell-free extracts by 2-chloro-2\u2032-deoxyadenosine 5\u2032-triphosphate and cytochrome c","volume":"95","author":"Leoni","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.12.009_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1074\/jbc.275.1.29","article-title":"Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway","volume":"275","author":"Genini","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.12.009_bib0045","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/sj.leu.2401845","article-title":"Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine","volume":"14","author":"Huang","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.12.009_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/mol.65.1.227","article-title":"The antileukemia drug 2-chloro-2\u2032-deoxyadenosine: an intrinsic transcriptional antagonist","volume":"65","author":"Hartman","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2010.12.009_bib0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0145-2126(90)90167-8","article-title":"Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement","volume":"14","author":"Saltman","year":"1990","journal-title":"Leuk Res"},{"key":"10.1016\/j.bcp.2010.12.009_bib0060","first-page":"3559","article-title":"Resistance to 2-chloro-2\u2032-deoxyadenosine of the human B-cell leukemia cell line EHEB","volume":"7","author":"Cardoen","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2010.12.009_bib0065","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1081\/NCN-200027653","article-title":"Effects of 2-chloro-2\u2032-deoxyadenosine on the cell cycle in the human leukemia EHEB cell line","volume":"23","author":"Cardoen","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.bcp.2010.12.009_bib0070","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1038\/sj.onc.1207229","article-title":"Mechanisms of apoptosis induction by nucleoside analogs","volume":"22","author":"Sampath","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.12.009_bib0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cell.2003.08.001","article-title":"UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair","volume":"114","author":"Bendjennat","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.12.009_bib0080","doi-asserted-by":"crossref","first-page":"26876","DOI":"10.1074\/jbc.M605366200","article-title":"UV Induces p21 rapid turnover independently of ubiquitin and Skp2","volume":"281","author":"Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.12.009_bib0085","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/MCB.01461-06","article-title":"Glycogen synthase kinase 3beta phosphorylates p21WAF1\/CIP1 for proteasomal degradation after UV irradiation","volume":"27","author":"Lee","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.12.009_bib0090","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1038\/sj.onc.1209315","article-title":"P21Cip1\/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation","volume":"25","author":"Soria","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.12.009_bib0095","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.bcp.2007.12.007","article-title":"Mechanisms of cell death induced by 2-chloroadenosine in leukemic B-cells","volume":"75","author":"Bastin-Coyette","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.12.009_bib0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2010.12.009_bib0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1097-2765(04)00259-X","article-title":"Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage","volume":"14","author":"Kannouche","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2010.12.009_bib0110","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1124\/mol.62.3.680","article-title":"Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine","volume":"62","author":"Sampath","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2010.12.009_bib0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abio.1999.4085","article-title":"Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro","volume":"270","author":"Winer","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2010.12.009_bib0120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.12.009_bib0125","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1182\/blood-2005-11-4465","article-title":"Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)","volume":"107","author":"Secchiero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.12.009_bib0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01575446","article-title":"The induction of p53 and WAF1\/CIP1 in chronic lymphocytic leukemia cells treated with 2-chlorodeoxyadenosine","volume":"74","author":"Gartenhaus","year":"1996","journal-title":"J Mol Med"},{"key":"10.1016\/j.bcp.2010.12.009_bib0135","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1073\/pnas.98.3.1036","article-title":"p53 accumulates but is functionally impaired when DNA synthesis is blocked","volume":"98","author":"Gottifredi","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.12.009_bib0140","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1006\/bbrc.1996.1546","article-title":"Proteasome-dependent regulation of p21WAF1\/CIP1 expression","volume":"227","author":"Blagosklonny","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2010.12.009_bib0145","doi-asserted-by":"crossref","first-page":"19207","DOI":"10.1074\/jbc.273.30.19207","article-title":"Cleavage of CDK inhibitor p21(Cip1\/Waf1) by caspases is an early event during DNA damage-induced apoptosis","volume":"273","author":"Gervais","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.12.009_bib0150","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1038\/sj.onc.1205449","article-title":"Enhanced tumor killing by Apo2L\/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L\/TRAIL ligand and its receptors","volume":"21","author":"Xiang","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.12.009_bib0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1097-2765(00)80435-9","article-title":"Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination","volume":"5","author":"Sheaff","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2010.12.009_bib0160","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/emboj\/20.10.2367","article-title":"A degradation signal located in the C-terminus of p21WAF1\/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome","volume":"20","author":"Touitou","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2010.12.009_bib0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0092-8674(03)00755-4","article-title":"Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation","volume":"115","author":"Bloom","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.12.009_bib0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4161\/cc.3.2.659","article-title":"To be or not to be ubiquitinated?","volume":"3","author":"Bloom","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2010.12.009_bib0175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.12.009_bib0180","first-page":"M43","article-title":"p21(WAF1\/Cip1): more than a break to the cell cycle?","volume":"1471","author":"Dotto","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2010.12.009_bib0185","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2007.05.003","article-title":"PCNA, the maestro of the replication fork","volume":"129","author":"Moldovan","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.12.009_bib0190","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.4161\/cc.7.24.7243","article-title":"The p21 and PCNA partnership: a new twist for an old plot","volume":"7","author":"Prives","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2010.12.009_bib0195","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4161\/cc.5.17.3193","article-title":"Keeping mammalian mutation load in check: regulation of the activity of error-prone DNA polymerases by p53 and p21","volume":"5","author":"Livneh","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2010.12.009_bib0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mrrev.2010.01.009","article-title":"Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response","volume":"704","author":"Cazzalini","year":"2010","journal-title":"Mutat Res"},{"key":"10.1016\/j.bcp.2010.12.009_bib0205","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1242\/jcs.027730","article-title":"p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation","volume":"121","author":"Soria","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bcp.2010.12.009_bib0210","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4161\/cc.3.8.1074","article-title":"Ubiquitination of PCNA and the polymerase switch in human cells","volume":"3","author":"Kannouche","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2010.12.009_bib0215","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-2952(02)01448-X","article-title":"Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine","volume":"65","author":"Galmarini","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.12.009_bib0220","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2008-05-156380","article-title":"p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism","volume":"112","author":"Steele","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.12.009_bib0225","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1182\/blood-2005-08-3273","article-title":"MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells","volume":"107","author":"Coll-Mulet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.12.009_bib0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.dnarep.2009.12.003","article-title":"PCNA-coupled p21 degradation after DNA damage: the exception that confirms the rule?","volume":"9","author":"Soria","year":"2010","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bcp.2010.12.009_bib0235","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1074\/jbc.M808810200","article-title":"Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells","volume":"284","author":"Stuart","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.12.009_bib0240","first-page":"153","article-title":"Ubiquitin-independent degradation of proteins by the proteasome","volume":"1786","author":"Jariel-Encontre","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2010.12.009_bib0245","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cellsig.2010.01.013","article-title":"Examination of the expanding pathways for the regulation of p21 expression and activity","volume":"22","author":"Jung","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.bcp.2010.12.009_bib0250","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1101\/gad.1676108","article-title":"PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex","volume":"22","author":"Abbas","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2010.12.009_bib0255","doi-asserted-by":"crossref","first-page":"29045","DOI":"10.1074\/jbc.M806045200","article-title":"CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation","volume":"283","author":"Nishitani","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.12.009_bib0260","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1093\/emboj\/cdg600","article-title":"MDM2 promotes p21waf1\/cip1 proteasomal turnover independently of ubiquitylation","volume":"22","author":"Jin","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2010.12.009_bib0265","doi-asserted-by":"crossref","first-page":"18407","DOI":"10.1074\/jbc.M109.059568","article-title":"MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change","volume":"285","author":"Xu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.12.009_bib0270","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1128\/MCB.01198-07","article-title":"MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2","volume":"28","author":"Jin","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.12.009_bib0275","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/MCB.01335-09","article-title":"14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer","volume":"30","author":"Wang","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.12.009_bib0280","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4161\/cc.5.12.2863","article-title":"The intricacies of p21 phosphorylation: protein\/protein interactions, subcellular localization and stability","volume":"5","author":"Child","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2010.12.009_bib0285","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1073\/pnas.95.21.12254","article-title":"Activity and nature of p21(WAF1) complexes during the cell cycle","volume":"95","author":"Cai","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.12.009_bib0290","doi-asserted-by":"crossref","first-page":"52052","DOI":"10.1074\/jbc.M307012200","article-title":"Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis","volume":"278","author":"Coulonval","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.12.009_bib0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2004.08.005","article-title":"Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle","volume":"217","author":"Golsteyn","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2010.12.009_bib0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1747-1028-4-9","article-title":"A dual role of Cdk2 in DNA damage response","volume":"4","author":"Satyanarayana","year":"2009","journal-title":"Cell Div"},{"key":"10.1016\/j.bcp.2010.12.009_bib0305","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1368-7646(03)00044-X","article-title":"Differential effects of cell cycle regulatory protein p21(WAF1\/Cip1) on apoptosis and sensitivity to cancer chemotherapy","volume":"6","author":"Liu","year":"2003","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.bcp.2010.12.009_bib0310","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1021\/bi000130k","article-title":"Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta","volume":"39","author":"Vaisman","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2010.12.009_bib0315","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1541-7786.MCR-05-0118","article-title":"A novel role of DNA polymerase eta in modulating cellular sensitivity to chemotherapeutic agents","volume":"4","author":"Chen","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2010.12.009_bib0320","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.leu.2405092","article-title":"A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL","volume":"22","author":"Best","year":"2008","journal-title":"Leukemia"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210008506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210008506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T20:56:04Z","timestamp":1592168164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210008506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0006295210008506"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.12.009","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}